Laobaixing Pharmacy Shareholders Approve Restricted Stock Incentive and Employee Stock Plan Covering 340+
Laobaixing Pharmacy's first temporary shareholders' meeting of 2026 approved a restricted stock incentive plan and an employee stock ownership plan covering more than 340 people, with net profit growth and individual performance as dual assessment criteria for fiscal years 2027 and 2028. The plan supports the company's digital and AI transformation, as reflected in its first-quarter 2026 results: revenue of RMB 5.481 billion, up 0.85%; net profit attributable to shareholders of RMB 264 million, up 5.27%; non-GAAP net profit of RMB 260 million, up 6.98%; and operating net cash flow up 6.76%.
Laobaixing Pharmacy held its first temporary shareholders' meeting of 2026 on August 26, approving six proposals, including the Draft 2026 Restricted Stock Incentive Plan, the Draft 2026 Employee Stock Ownership Plan, and related management measures. The incentive scheme combines restricted stock and employee stock ownership, covering more than 340 mid-to-senior managers and core business staff, with dual assessment criteria at the company level, focusing on net profit growth, and at the individual level, for fiscal years 2027 and 2028.
The equity incentive design favors core talent in information and digital AI business areas to support the company's digital and AI strategic transformation. Public data shows that Laobaixing established an AI application strategy committee in 2025, led by Chairman and President Xie Zilong, to promote AI applications in store operations, supply chain, new retail, and franchising. As of the end of the first quarter of 2026, Laobaixing operated over 15,000 stores nationwide, with quarterly revenue of RMB 5.481 billion, up 0.85% year on year; net profit attributable to shareholders of RMB 264 million, up 5.27%; non-GAAP net profit attributable to shareholders of RMB 260 million, up 6.98%; and operating net cash flow up 6.76% year on year.